Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 4343 [2020-01127]

Download as PDF Federal Register / Vol. 85, No. 16 / Friday, January 24, 2020 / Notices in the future through more detailed risk analyses conducted as part of NASA’s and the DOE’s ongoing radiological safety review programs. These analyses were completed in 2019 and accounted for the Atlas V as the chosen launch vehicle (that was selected on August 25, 2016, after the Mars 2020 Record of Decision on January 27, 2015), up-todate safety test information, and updated analytical models. NASA policy for implementation of NEPA is found in NASA Procedural Requirements 8580.1A (NPR). The NPR requires preparation of a supplemental NEPA document when significant new information relevant to environmental concerns that bear on the proposed action or its impacts is discovered. Since NASA issued the 2014 Final EIS and 2015 ROD, the updated results from the risk and consequence modeling have become available for NASA’s consideration. NASA has determined that the purposes of NEPA will be furthered by preparation and issuance of a SEIS. Calvin F. Williams, Associate Administrator, Office of Strategic Infrastructure, Mission Support Directorate. [FR Doc. 2020–01179 Filed 1–23–20; 8:45 am] BILLING CODE 7510–13–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) will convene a teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on March 11, 2020, to discuss the draft report of the ACMUI Regulatory Guide 8.39 Subcommittee. A phased approach is being conducted by the NRC staff to comprehensively update Regulatory Guide 8.39, ‘‘Release of Patients Administered Radioactive Material.’’ Phase 1 of the revision provides licensees with more detailed instructions to patients before and after they have been administered radioactive material than what is currently provided in Regulatory Guide 8.39. The ACMUI subcommittee’s report will include its comments and recommendations on the draft final Phase 1 revisions to Regulatory Guide 8.39. Meeting information, including a copy of the agenda and handouts, will be available at http://www.nrc.gov/reading-rm/doc- lotter on DSKBCFDHB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:03 Jan 23, 2020 Jkt 250001 collections/acmui/meetings/2020.html. The agenda and handouts may also be obtained by contacting Ms. Kellee Jamerson using the information below. DATES: The teleconference meeting will be held on Wednesday, March 11, 2020, 2:00 p.m. to 4:00 p.m. Eastern Time. FOR FURTHER INFORMATION CONTACT: Kellee Jamerson, email: Kellee.Jamerson@nrc.gov, telephone: (301) 415–7408. SUPPLEMENTARY INFORMATION: Public Participation: Any member of the public who wishes to participate in the teleconference should contact Ms. Jamerson using the contact information in FOR FURTHER INFORMATION CONTACT. Conduct of the Meeting Dr. Darlene Metter, ACMUI Chairman, will preside over the meeting. Dr. Metter will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Jamerson at the contact information listed above. All written statements must be received by March 6, 2020, three business days prior to the meeting, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting at the discretion of the ACMUI Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s website http://www.nrc.gov/reading-rm/ doc-collections/acmui/meetings/ 2020.html on or about April 22, 2020. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in 10 CFR part 7. Dated: January 17, 2020. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2020–01127 Filed 1–23–20; 8:45 am] BILLING CODE 7590–01–P POSTAL REGULATORY COMMISSION [Docket Nos. CP2017–232; CP2017–242; CP2017–249; CP2017–251; CP2017–254; CP2017–255; CP2019–50; CP2019–70; CP2019–110] 4343 The Commission is noticing a recent Postal Service filing for the Commission’s consideration concerning negotiated service agreements. This notice informs the public of the filing, invites public comment, and takes other administrative steps. DATES: Comments are due: January 27, 2020. ADDRESSES: Submit comments electronically via the Commission’s Filing Online system at http:// www.prc.gov. Those who cannot submit comments electronically should contact the person identified in the FOR FURTHER INFORMATION CONTACT section by telephone for advice on filing alternatives. SUMMARY: FOR FURTHER INFORMATION CONTACT: David A. Trissell, General Counsel, at 202–789–6820. SUPPLEMENTARY INFORMATION: Table of Contents I. Introduction II. Docketed Proceeding(s) I. Introduction The Commission gives notice that the Postal Service filed request(s) for the Commission to consider matters related to negotiated service agreement(s). The request(s) may propose the addition or removal of a negotiated service agreement from the market dominant or the competitive product list, or the modification of an existing product currently appearing on the market dominant or the competitive product list. Section II identifies the docket number(s) associated with each Postal Service request, the title of each Postal Service request, the request’s acceptance date, and the authority cited by the Postal Service for each request. For each request, the Commission appoints an officer of the Commission to represent the interests of the general public in the proceeding, pursuant to 39 U.S.C. 505 (Public Representative). Section II also establishes comment deadline(s) pertaining to each request. The public portions of the Postal Service’s request(s) can be accessed via the Commission’s website (http:// www.prc.gov). Non-public portions of the Postal Service’s request(s), if any, can be accessed through compliance with the requirements of 39 CFR 3007.301.1 The Commission invites comments on whether the Postal Service’s request(s) New Postal Products Postal Regulatory Commission. ACTION: Notice. AGENCY: PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 1 See Docket No. RM2018–3, Order Adopting Final Rules Relating to Non-Public Information, June 27, 2018, Attachment A at 19–22 (Order No. 4679). E:\FR\FM\24JAN1.SGM 24JAN1

Agencies

[Federal Register Volume 85, Number 16 (Friday, January 24, 2020)]
[Notices]
[Page 4343]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01127]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
teleconference meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on March 11, 2020, to discuss the draft report of the 
ACMUI Regulatory Guide 8.39 Subcommittee. A phased approach is being 
conducted by the NRC staff to comprehensively update Regulatory Guide 
8.39, ``Release of Patients Administered Radioactive Material.'' Phase 
1 of the revision provides licensees with more detailed instructions to 
patients before and after they have been administered radioactive 
material than what is currently provided in Regulatory Guide 8.39. The 
ACMUI subcommittee's report will include its comments and 
recommendations on the draft final Phase 1 revisions to Regulatory 
Guide 8.39. Meeting information, including a copy of the agenda and 
handouts, will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html. The agenda and handouts may also 
be obtained by contacting Ms. Kellee Jamerson using the information 
below.

DATES: The teleconference meeting will be held on Wednesday, March 11, 
2020, 2:00 p.m. to 4:00 p.m. Eastern Time.

FOR FURTHER INFORMATION CONTACT: Kellee Jamerson, email: 
[email protected], telephone: (301) 415-7408.

SUPPLEMENTARY INFORMATION: 
    Public Participation: Any member of the public who wishes to 
participate in the teleconference should contact Ms. Jamerson using the 
contact information in FOR FURTHER INFORMATION CONTACT.

Conduct of the Meeting

    Dr. Darlene Metter, ACMUI Chairman, will preside over the meeting. 
Dr. Metter will conduct the meeting in a manner that will facilitate 
the orderly conduct of business. The following procedures apply to 
public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Jamerson at the contact information listed 
above. All written statements must be received by March 6, 2020, three 
business days prior to the meeting, and must pertain to the topic on 
the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting at the discretion of the ACMUI Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html on or about April 22, 2020.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.

    Dated: January 17, 2020.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2020-01127 Filed 1-23-20; 8:45 am]
 BILLING CODE 7590-01-P